[go: up one dir, main page]

Takasugi et al., 1971 - Google Patents

The methodology of microassay for cell-mediated immunity (MCI)

Takasugi et al., 1971

Document ID
9563508235409972800
Author
Takasugi M
Klein E
Publication year
Publication venue
In vitro methods in cell-mediated immunity

External Links

Snippet

Publisher Summary The microassay for cell-mediated immunity detects histocompatibility and tumor-specific antigens with sensitivity and clarity. In this microassay, around 1000 target cells and a maximum of 50, 000 effect or cells are cultured in 10 microliters of medium …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Similar Documents

Publication Publication Date Title
Hershman et al. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients
Li et al. Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
Ottesen et al. The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man
Modlin et al. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
Wright et al. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Laal et al. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum
Sheldon et al. Studies on synovial fluid lymphocytes in rheumatoid arthritis
KR20230008691A (en) Ex vivo culture, induction, activation, cryopreservation method of immune cells and construction of the cell bank
EP2859092B1 (en) Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying treg cells to produce therapeutic vaccine for treatment of diabetes type 1
Miller et al. The lymphocytic origin of a plasma factor responsible for hypersensitivity in vitro of tuberculin type
Dong et al. Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1. 1+ cells
Orrantia et al. Human NK cells in autologous hematopoietic stem cell transplantation for cancer treatment
WO2000024420A1 (en) Method for the production of an antiviral agent
Takasugi et al. The methodology of microassay for cell-mediated immunity (MCI)
Yannelli et al. Enhancement of human lymphokine-activated killer cell cytolysis and a method for increasing lymphokine-activated killer cell yields to cancer patients
Bloom et al. Monocyte-mediated augmentation of human natural cell-mediated cytotoxicity
US6692958B2 (en) Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations
JPH11292772A (en) Preparation containing allogenic activated cd4 positive cell as main ingredient and production of the preparation
Cohn [76] The isolation and cultivation of mononuclear phagocytes
Krikorian et al. Counts and characteristics of macrophage precursors in human peripheral blood
Moore et al. ISOANTIGENS OF CULTURED HUMAN LYMPHOID CELLS¹
Pancre et al. IgE-dependent killing of Brugia malayi microfilariae by human platelets and its modulation by T cell products
Bray et al. Lithium and the mitogenic response of human lymphocytes
Amato et al. Separation of immunocompetent cells from human and mouse hemopoietic cell suspensions by velocity sedimentation
Wislöff et al. Studies on the cytotoxic activity of human lymphoid cells activated by concanavalin A